Hi Morf. My thanks for your posts too. One other question please: did the subject of future capital needs come up in your discussion with the CEO?Cheers, Z
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling